Protocol Ledger

NCT06861101 · Phase II · COMPLETED

Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

Interventional Phase II clinical trial protocol NCT06861101 sponsored by Shanghai JunTop Biosciences Co in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-02-24 Enrollment: 370 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06861101
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)370 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06861101
Protocol FieldVerified Registry Value
NCT IdentifierNCT06861101
Consolidated Lead SponsorShanghai JunTop Biosciences Co
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment370 participants (ACTUAL)
Registered Start Date2025-02-24
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06861101
Hospital Research SiteLocationSite Profile
Peking University Third HospitalBeijing, ChinaOpen Hospital Dossier ->
Fujian Medical University Union HospitalFuzhou, ChinaOpen Hospital Dossier ->
The First Affiliated Hospital Of Fujian Medical UniversityFuzhou, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI